Disc Medicine to Participate in Upcoming Investor Conferences

Core Insights - Disc Medicine, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for serious hematologic diseases [3] - The company will participate in four upcoming investor conferences in September 2024 [1] Conference Participation - The company will present at the 2024 Wells Fargo Securities Healthcare Conference on September 6th at 10:15 a.m. ET [1] - The Morgan Stanley 22nd Annual Global Healthcare Conference will also feature the company on September 6th at 1:05 p.m. ET [1] - The H.C. Wainwright 26th Annual Global Investment Conference is scheduled for September 11th at 9:30 a.m. ET [1] - The 2024 Cantor Global Healthcare Conference will take place on September 19th at 8:00 a.m. ET [1] Webcast Information - A live webcast of the fireside chats will be available on the company's investor relations website, with an archived replay accessible after the events [2]